Marine sponge steroids as nuclear receptor ligands

Trends in Pharmacological Sciences

Volumn 33, Issue 11, 2012, Pages 591-601

  Fiorucci, Stefano ^a   Distrutti, Eleonora ^b   Bifulco, Giuseppe ^c   D'Auria, Maria Valeria ^d   Zampella, Angela ^d  

^a Nuova Facoltà di Medicina   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID; CELL NUCLEUS RECEPTOR; CONICASTEROL; CONICASTEROL B; CONICASTEROL D; FARNESOID X RECEPTOR; FARNESOID X RECEPTOR AGONIST; FARNESOID X RECEPTOR ANTAGONIST; GUGGULSTERONE; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; HYPERFORIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OBETICHOLIC ACID; PHENOBARBITAL; PREGNANE X RECEPTOR; RIFAXIMIN; SOLOMONSTEROL A; SOLOMONSTEROL B; SOLOMONSTEROL DERIVATIVE; STEROID; SWINHOSTEROL B; THEONELLASTEROL; THEONELLASTEROL C; THEONELLASTEROL E; THEONELLASTEROL F; THEONELLASTEROL G; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

CHOLESTASIS; DRUG IDENTIFICATION; DRUG TARGETING; ENTERITIS; HEPATIC ENCEPHALOPATHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; LIVER PROTECTION; MARINE SPECIES; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PRURITUS; REVIEW; TRAVELLER DIARRHEA; XENOBIOTIC METABOLISM;

ANIMALS; BILE ACIDS AND SALTS; CHOLANES; EVOLUTION, MOLECULAR; HUMANS; LIGANDS; NF-KAPPA B; PORIFERA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; STEROLS; SULFURIC ACID ESTERS;

EID: 84867894196     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.08.004     Document Type: Review

References (78)

1. M. Pawlak General molecular biology and architecture of nuclear receptors Curr. Top. Med. Chem. 12 2012 486 504
2. A.R. de Lera Design of selective nuclear receptor modulators: RAR and RXR as a case study Nat. Rev. Drug Discov. 6 2007 811 820
3. I.G. Schulman Nuclear receptors as drug targets for metabolic disease Adv. Drug Deliv. Rev. 62 2010 1307 1315
4. J.T. Bridgham Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor PLoS Biol. 8 2010 e1000497
5. F.M. Sladek What are nuclear receptor ligands? Mol. Cell. Endocrinol. 334 2011 3 13
6. S. Kumar, and S.B. Hedges A molecular timescale for vertebrate evolution Nature 392 1998 917 920
7. A.F. Hofmann Bile salts of vertebrates: structural variation and possible evolutionary significance J. Lipid Res. 51 2010 226 246
8. V.A. Stonik Marine polar steroids Russ. Chem. Rev. 70 2001 673 715
9. M.V. D'Auria Polyoxygenated steroids of marine origin Chem. Rev. 93 1993 1839 1895
10. N.S. Sarma Sterol ring system oxidation pattern in marine sponges Mar. Drugs 3 2005 84 111
11. D. Sica Secosteroids of marine origin Steroids 69 2004 743 756
12. B.R. Moser Review of cytotoxic cephalostatins and ritterazines: isolation and synthesis Chem. Rev. 109 2009 2275 2314
13. S. Aoki Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids Bioorg. Med. Chem. 15 2007 6758 6762
14. M.V. D'Auria Natural ligands for nuclear receptors: biology and potential therapeutic applications Curr. Top. Med. Chem. 12 2012 637 669
15. S. Kyoungjin Sterols from a soft coral, Dendronephthya gigantea as farnesoid X-activated receptor antagonists Steroids 77 2012 355 359
16. M.Y. Putra Polyhydroxylated sterols from the Indonesian soft coral Sinularia sp. and their effect on farnesoid X-activated receptor Steroids 77 2012 433 440
17. H. Jayasuriya Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources J. Nat. Prod. 68 2005 1247 1252
18. J.W. Jonker FXR and PXR: potential therapeutic targets in cholestasis J. Steroid Biochem. Mol. Biol. 130 2012 147 158
19. D.D. Moore The NR1H and NR1I receptors: constitutive androstane receptor, pregnane X receptor, farnesoid X receptor α, farnesoid X receptor β, liver X receptor α, liver X receptor β, and vitamin D receptor Pharmacol. Rev. 58 2006 742 759
20. D.J. Parks Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
21. M. Downes A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR Mol. Cell 11 2003 1079 1092
22. G. Rizzo The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes Mol. Pharmacol. 68 2005 551 558
23. C.J. Sinal Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
24. M. Honda Differential gene expression profiles in stage I primary biliary cirrhosis Am. J. Gastroenterol. 100 2005 2019 2030
25. S. Fiorucci Targeting farnesoid-X-receptor: from medicinal chemistry to disease treatment Curr. Med. Chem. 17 2010 139 159
26. J.M. Lee Expression of the bile salt export pump is maintained after chronic cholestasis in the rat Gastroenterology 118 2000 163 172
27. G.A. Kullak-Ublick Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver Gastroenterology 120 2001 525 533
28. N. Ballatori OSTα-OSTβ: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia Hepatology 42 2005 1270 1279
29. G. Zollner Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis J. Hepatol. 38 2003 717 727
30. J.Y. Chiang Bile acids: regulation of synthesis J. Lipid Res. 50 2009 1955 1966
31. C.D. Klaassen, and L.M. Aleksunes Xenobiotic, bile acid, and cholesterol transporters: function and regulation Pharmacol. Rev. 62 2010 1 96
32. R.O. Elferink, and A.K. Groen Genetic defects in hepatobiliary transport Biochim. Biophys. Acta 1586 2002 129 145
33. A. Geier Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration Biochim. Biophys. Acta 1773 2007 283 308
34. T. Inagaki Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab. 2 2005 217 225
35. B. Renga Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition FASEB J. 26 2012 3021 3031
36. D. Jung Pregnane X receptor is a target of farnesoid X receptor J. Biol. Chem. 281 2006 19081 19091
37. J.M. Lehmann The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J. Clin. Invest. 102 1998 1016 1023
38. O. Barbier FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity Gastroenterology 124 2003 1926 1940
39. B. Cariou The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis Diabetes Metab. 34 2008 685 691
40. R.E. Poupon Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis Hepatology 29 1999 1668 1671
41. A. Pares Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720
42. Y. Gong Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses Am. J. Gastroenterol. 102 2007 1799 1807
43. P.R. Maloney Identification of a chemical tool for the orphan nuclear receptor FXR J. Med. Chem. 43 2000 2971 2974
44. R. Pellicciari Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives J. Med. Chem. 49 2006 4208 4215
45. S. Fiorucci Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA Mini Rev. Med. Chem. 11 2011 753 762
46. S. Fiorucci Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis J. Pharmacol. Exp. Ther. 313 2005 604 612
47. S. Fiorucci The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis Gastroenterology 127 2004 1497 1512
48. R.R. Henry Farnesoid-X receptor agonists: a new therapeutic class for diabetes and fatty liver disease? The first FXR therapeutic study in diabetes Abstracts of the 69th Annual Meeting of the Diabetes Association 2009 Abstract 13-LB
49. D. Shapiro First human experience with a synthetic farnesoid X receptor (FXR) agonist, INT-747 (6α-ethylchenodeoxycholic acid) Hepatology 50 Suppl. 2009 770A 771A
50. A. Mason Farnesoid-X receptor agonists: a new class of drugs for the treatment of PBC? An international study evaluating the addition of INT-747 to ursodeoxycholicacid J. Hepatol. 52 2010 S1 S2
51. C. Stedman Benefit of farnesoid X receptor inhibition in obstructive cholestasis Proc. Natl. Acad. Sci. U.S.A. 103 2006 11323 11328
52. B. Renga Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter Biochim. Biophys. Acta 1809 2011 157 165
53. J. Wu The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor Mol. Endocrinol. 16 2002 1590 1597
54. T.P. Burris The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand Mol. Pharmacol. 67 2005 948 954
55. S. De Marino Theonellasterols and conicasterols from Theonella swinhoei. Novel marine natural ligands for human nuclear receptors J. Med. Chem. 54 2011 3065 3075
56. S. De Marino Towards new ligands of nuclear receptors. Discovery of malaitasterol A, a unique bis-secosterol from marine sponge Theonella swinhoei Org. Biomol. Chem. 9 2011 4856 4862
57. V. Sepe Conicasterol E, a small heterodimer partner sparing farnesoid-X-receptor modulator endowed with a pregnane-X-receptor agonistic activity, from the marine sponge Theonella swinhoei J. Med. Chem. 55 2012 84 93
58. 13C chemical shifts in the stereochemical determination of conicasterol F, a nuclear receptor ligand from Theonella swinhoei J. Org. Chem. 77 2012 1489 1496
59. S. De Marino 4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity Steroids 77 2012 484 495
60. B. Renga Discovery of theonellasterol a marine sponge sterol as a highly selective FXR antagonist that protects against liver injury in cholestasis PLoS ONE 7 2012 e30443
61. V. Sepe Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor J. Med. Chem. 54 2011 1314 1320
62. C.A. Stedman Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury Proc. Natl. Acad. Sci. U.S.A. 102 2005 2063 2068
63. S. Fiorucci Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders Curr. Top. Med. Chem. 12 2012 605 624
64. J. Cheng Pregnane X receptor as a target for treatment of inflammatory bowel disorders Trends Pharmacol. Sci. 33 2012 323 330
65. Y.M. Shah Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expression Am. J. Physiol. Gastrointest. Liver Physiol. 292 2007 G1114 G1122
66. S. Fiorucci Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis Immunity 17 2002 769 780
67. J. Cheng Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation J. Pharmacol. Exp. Ther. 335 2010 32 41
68. X. Ma Rifaximin is a gut-specific human pregnane X receptor activator J. Pharmacol. Exp. Ther. 322 2007 391 398
69. A. Mencarelli Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells Eur. J. Pharmacol. 668 2011 317 324
70. A. Mencarelli Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells Biochem. Pharmacol. 80 2010 1700 1707
71. X. Gu Role of NF-κB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents J. Biol. Chem. 281 2006 17882 17889
72. H. Uppal Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice Hepatology 41 2005 168 176
73. J. Zhou A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway J. Biol. Chem. 281 2006 15013 15020
74. M.J. Liu The aldo-ketoreductase Akr1b7 gene is a common transcriptional target of xenobiotic receptors pregnane X receptor and constitutive androstane receptor Mol. Pharmacol. 76 2009 604 611
75. C. Festa Solomonsterols A and B from Theonella swinhoei. The first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity J. Med. Chem. 54 2011 401 405
76. V. Sepe Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist Org. Biomol. Chem. 10 2012 6350 6362
77. V. Sepe The first total synthesis of solomonsterol B a marine pregnane X receptor agonist Eur. J. Org. Chem. 2012 10.1002/ejoc.201200619
78. V. Sepe Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity J. Med. Chem. 54 2011 4590 4599